Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Scientific News Boston Scientific S Upside With Cardiology Devices Drives Momentum

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific S Upside With Cardiology Devices Drives Momentum is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Scientific News Boston Scientific S Upside With Cardiology Devices Drives Momentum | RobinsPost News & Noticias

Boston Scientific (BSX): Evaluating Valuation After Strong Q3 Results and New Product Launches


Boston Scientific (BSX) is in the spotlight after reporting third-quarter financial results that show strong sales growth and operational execution. The company has also expanded its medical device ... Read More

Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story?


Boston Scientific Corp. (NYSE:BSX) is one of the best stocks to buy according to Citadel LLC. On October 22, Josh Jennings, an analyst at TD Cowen, reiterated his $115 price target and Buy rating on ... Read More

Boston Scientific rises as cardiology sales drive Q3 beat, guidance boost


Boston Scientific (NYSE:BSX) traded higher on Wednesday after the MedTech giant exceeded Street forecasts with its Q3 2025 results and boosted its full-year outlook following better-than-expected ... Read More

Boston Scientific Q3: Operational Improvements Warrant An Upgrade To A Buy


Boston Scientific posts strong Q3 growth and upgrades 2025 outlook. See why BSX stock is rated Buy and what drives its leadership. Read More

Boston Scientific Jumps On Strong Guidance, Heart Devices Fuel Topline Growth


Boston Scientific Corporation (NYSE:BSX) reported third-quarter 2025 revenues of $5.07 billion on Wednesday, beating the consensus estimate of $4.97 billion. The medical technology giant reported ... Read More

Boston Scientific Corporation (BSX) Expands AI-Enhanced Heart Devices With FARAPULSE Approval


In this article, we will be taking a look at the Top 10 AI-Powered Biotech Stocks to Buy Now. Boston Scientific Corporation is one of them Boston Scientific Corporation (NYSE:BSX) is emerging as a top ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus